ONO-2808
Asset
Investigational therapeutic agent for the treatment of multiple system atrophy.
- Stage
- Phase 2
- Modality
- Small molecule
- Target
- Not known
- 1
- Indication
- 1
- Trial
- 1
- Developer
Indications
1Multiple system atrophy
Phase 2, Active not recruiting, NCT05923866, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Owner and partners1
- Trials1
- Competitors2
Every asset’s record: target, stage, trials and the evidence behind it.
Updated 7 Oct 2026, 1 source